Biocept reports q1 loss per share of $0.11

Biocept reports first quarter 2020 financial results.q1 loss per share $0.11.q1 revenue rose 41 percent to $1.4 million.reported cash and cash equivalents as of march 31, 2020 of $21.5 million, compared with $9.3 million as of december 31, 2019.

BIOC Ratings Summary

BIOC Quant Ranking